Reata stock

Reata stock 14 hours ago · In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ... May 11, 2023 · Reata Pharmaceuticals, Inc. (RETA Quick Quote RETA - Free Report) reported a first-quarter 2023 adjusted loss of $3.14 per share, wider than the Zacks Consensus Estimate and our model estimate of ... A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on …Reata Pharmaceuticals, Inc. (RETA Quick Quote RETA - Free Report) reported a first-quarter 2023 adjusted loss of $3.14 per share, wider than the Zacks Consensus Estimate and our model estimate of ...25malxpremium crickets Reata Pharmaceuticals stock price target raised to $210 from $135 at Stifel NicolausSimply Wall St. Business Wire. PLANO, Texas, May 10, 2023--Reata Pharmaceuticals, Inc. (Nasdaq: RETA) ("Reata," the "Company," "our," "us," or "we"), a global biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, today announced financial results for the first quarter of 2023 and ...Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease ...What was the 52-week low for Reata Pharmaceuticals stock? The low in …May 25, 2023 · Swiss National Bank grew its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA - Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 64,800 shares of the company's stock after ac cafe airlie May 25, 2023 · Swiss National Bank grew its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA - Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 64,800 shares of the company's stock after ac Mar 2, 2023 · Reata expects the drug to be available commercially in the second quarter of 2023. Several analysts hiked their price targets on the stock after the FDA’s approval for Skyclarys. In addition to ... Reata Pharmaceuticals Inc’s ( RETA) price is currently up 2.72% so far this month. During the month of February, Reata Pharmaceuticals Inc’s stock price has reached a high of $51.98 and a low of $37.80. Over the last year, Reata Pharmaceuticals Inc has hit prices as high as $51.98 and as low as $18.47. Year to date, Reata Pharmaceuticals ...A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease ...May 19, 2023 · What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ... Reata's stock jumps 175% in premarket trading after FDA approval Shares of Reata Pharmaceuticals Inc. RETA soared about 175% in premarket trading on Wednesday, the day after the Food and Drug Administration approved Skyclarys, a treatment for Friedreich's ataxia, a...14 hours ago · In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ... fluffy bag What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...View the latest Reata Pharmaceuticals Inc. Cl A (RETA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ...Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease ... mala project What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...May 11, 2023 · Reata Pharmaceuticals, Inc. (RETA Quick Quote RETA - Free Report) reported a first-quarter 2023 adjusted loss of $3.14 per share, wider than the Zacks Consensus Estimate and our model estimate of ... Mar 2, 2023 · Reata expects the drug to be available commercially in the second quarter of 2023. Several analysts hiked their price targets on the stock after the FDA’s approval for Skyclarys. In addition to ... Reata Pharmaceuticals stock surged on Wednesday after it received U.S. regulatory approval for a drug treating a rare neurological disorder. Analysts expect the decision to generate strong revenue ...Reata Pharmaceuticals Inc. (NASDAQ:RETA) shares, rose in value on Wednesday, 05/24/23, with the stock price up by 20.37% to the previous day’s close as strong demand from buyers drove the stock to $95.36. Actively observing the price movement in the last trading, the stock closed the session at $79.22, falling within a …Discover historical prices for RETA stock on Yahoo Finance. View daily, weekly or monthly format back to when Reata Pharmaceuticals, Inc. stock was issued.Reata Pharmaceuticals recently received FDA approval for Skyclarys, the first drug approved to treat Friedreich's ataxia. See why I rate RETA stock a hold. doordash login merchant Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news …What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...About Reata Pharmaceuticals, Inc. 5320 LEGACY DRIVE, PLANO, Texas, 75024, United States +1 972 865-2219 https://www.reatapharma.com. Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical ...Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ...View the latest Reata Pharmaceuticals Inc. Cl A (RETA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease ... mandy's soul food kitchen menu What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...May 25, 2023 · Swiss National Bank grew its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA - Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 64,800 shares of the company's stock after ac Mar 1, 2023 · Reata Pharmaceuticals stock surged on Wednesday after it received U.S. regulatory approval for a drug treating a rare neurological disorder. Analysts expect the decision to generate strong revenue ... Reata Pharmaceuticals ( NASDAQ: RETA) lost ~18% in the morning hours Wednesday despite reporting better than expected revenue for Q1 2023 as the biotech announced its plans to discontinue its ...A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. reggae pot sushi goken Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) After-Hours Stock Quotes - … chipotle fargoReata expects the drug to be available commercially in the second quarter of 2023. Several analysts hiked their price targets on the stock after the FDA’s approval for Skyclarys. In addition to ...Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ...Apr 13, 2023 · Reata Pharmaceuticals Inc (RETA) stock is trading at $96.63 as of 3:23 PM on Thursday, Apr 13, a rise of $0.14, or 0.15% from the previous closing price of $96.49. Volume today is below average. So far 303,929 shares have traded compared to average volume of 1,486,483 shares. The stock has traded between $96.10 and $98.89 so far today. May 23, 2023 · Institutional investors own 76.13% of the company's stock. Insider Buying and Selling at Reata Pharmaceuticals. In other Reata Pharmaceuticals news, insider Michael D. Wortley sold 894 shares of Reata Pharmaceuticals stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $84.81, for a total transaction of ... vietnam near me Goldman Sachs analyst Paul Choi maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report) today. The company’s shares closed yesterday at $79.22. According to TipRanks, Choi is ...Reata expects the drug to be available commercially in the second quarter of 2023. Several analysts hiked their price targets on the stock after the FDA’s approval for Skyclarys. In addition to ...Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ...What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...22 hours ago · Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ... May 19, 2023 · What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ... May 11, 2023 · Reata Pharmaceuticals, Inc. (RETA Quick Quote RETA - Free Report) reported a first-quarter 2023 adjusted loss of $3.14 per share, wider than the Zacks Consensus Estimate and our model estimate of ... Find the latest Reata Pharmaceuticals, Inc. (RETA) stock quote, history, news and other …Reata Pharmaceuticals, Inc. (RETA) Soars 6.3%: Is Further Upside Left in the Stock? … dolar a bolivarWhat was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...Price Target. Based on short-term price targets offered by 10 analysts, the average price target for Reata Pharmaceuticals, Inc. comes to $106.30. The forecasts range from a low of $75.00 to a ...May 23, 2023 · Institutional investors own 76.13% of the company's stock. Insider Buying and Selling at Reata Pharmaceuticals. In other Reata Pharmaceuticals news, insider Michael D. Wortley sold 894 shares of Reata Pharmaceuticals stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $84.81, for a total transaction of ... 14 hours ago · In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ... Reata Pharmaceuticals Inc’s ( RETA) price is currently up 2.72% so far this month. During the month of February, Reata Pharmaceuticals Inc’s stock price has reached a high of $51.98 and a low of $37.80. Over the last year, Reata Pharmaceuticals Inc has hit prices as high as $51.98 and as low as $18.47. Year to date, Reata Pharmaceuticals ... sal's gilbert pizza menu A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Goldman Sachs analyst Paul Choi maintained a Buy rating on Reata …Reata Pharmaceuticals ( NASDAQ: RETA) lost ~18% in the morning hours Wednesday despite reporting better than expected revenue for Q1 2023 as the biotech announced its plans to discontinue its ...Reata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease ...Reata’s stock jumps 175% in premarket trading after FDA approval Mar. 1, …View the latest Reata Pharmaceuticals Inc. Cl A (RETA) stock price, news, historical charts, analyst ratings and financial information from WSJ.Reata Pharmaceuticals ( NASDAQ: RETA) lost ~18% in the morning hours Wednesday despite reporting better than expected revenue for Q1 2023 as the biotech announced its plans to discontinue its ...Reata Pharmaceuticals Inc. (NASDAQ:RETA) shares, rose in value on Wednesday, 05/24/23, with the stock price up by 20.37% to the previous day’s close as strong demand from buyers drove the stock to $95.36. Actively observing the price movement in the last trading, the stock closed the session at $79.22, falling within a …Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.May 25, 2023 · Swiss National Bank grew its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA - Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 64,800 shares of the company's stock after ac 14 hours ago · In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ... May 11, 2023 · Reata Pharmaceuticals, Inc. (RETA Quick Quote RETA - Free Report) reported a first-quarter 2023 adjusted loss of $3.14 per share, wider than the Zacks Consensus Estimate and our model estimate of ... Reata Pharmaceuticals Inc’s ( RETA) price is currently up 2.72% so far this month. During the month of February, Reata Pharmaceuticals Inc’s stock price has reached a high of $51.98 and a low of $37.80. Over the last year, Reata Pharmaceuticals Inc has hit prices as high as $51.98 and as low as $18.47. Year to date, Reata Pharmaceuticals ...A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on …22 hours ago · Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ... May 19, 2023 · Reata Pharmaceuticals stock price target raised to $210 from $135 at Stifel Nicolaus freeportmcmoran Reata's stock jumps 175% in premarket trading after FDA approval. Shares of Reata Pharmaceuticals Inc. RETA soared about 175% in premarket trading on Wednesday, the day after the Food and Drug Administration approved Skyclarys, a treatment for Friedreich's ataxia, a... 2 months ago - Market Watch.Reata Pharmaceuticals ( NASDAQ: RETA) lost ~18% in the morning hours Wednesday despite reporting better than expected revenue for Q1 2023 as the biotech announced its plans to discontinue its ...May 23, 2023 · Institutional investors own 76.13% of the company's stock. Insider Buying and Selling at Reata Pharmaceuticals. In other Reata Pharmaceuticals news, insider Michael D. Wortley sold 894 shares of Reata Pharmaceuticals stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $84.81, for a total transaction of ... art of pizza on state street taco bravo gogobop14 hours ago · In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ... Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) After-Hours Stock Quotes - …Price Target. Based on short-term price targets offered by 10 analysts, the average price target for Reata Pharmaceuticals, Inc. comes to $106.30. The forecasts range from a low of $75.00 to a ...Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.Shares of Reata Pharmaceuticals ( RETA 0.50%) got hammered in early … the cracked egg of grosse pointe Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.Reata Pharmaceuticals Inc. RETA reported second-quarter 2021 loss of $2.00 per share, narrower than the Zacks Consensus Estimate of a loss of $2.13. However, the above loss included stock-based ... flippin good May 19, 2023 · What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ... Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) Stock … zaab der Reata Pharmaceuticals, Inc. Daily – Vickers Top Buyers & Sellers for 05/18/2023 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase ...In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ...Reata Pharmaceuticals recently received FDA approval for Skyclarys, the first drug approved to treat Friedreich's ataxia. See why I rate RETA stock a hold.Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. 5th ave market moge tea menuDiscover historical prices for RETA stock on Yahoo Finance. View daily, weekly or monthly format back to when Reata Pharmaceuticals, Inc. stock was issued. Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ... block earnings See the latest Reata Pharmaceuticals Inc Class A stock price …Swiss National Bank grew its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA - Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.The fund owned 64,800 shares of the company's stock after acquiring an additional 1,500 shares during …Reata also updated its cash guidance, indicating a cash runway until the end of 2026, thanks to existing cash, cash equivalents, marketable securities, and a newly-secured debt facility worth $275M.Reata Pharmaceuticals, Inc. Daily – Vickers Top Buyers & Sellers for 05/18/2023 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase ...Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC … cafe on the ave menu Mar 20, 2023 · About Reata Pharmaceuticals, Inc. 5320 LEGACY DRIVE, PLANO, Texas, 75024, United States +1 972 865-2219 https://www.reatapharma.com. Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical ... Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.May 19, 2023 · What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ... View the latest Reata Pharmaceuticals Inc. Cl A (RETA) stock price, news, historical …Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Reata also updated its cash guidance, indicating a cash runway until the end of 2026, thanks to existing cash, cash equivalents, marketable securities, and a newly-secured debt facility worth $275M. dickie collar Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) After-Hours Stock Quotes - …May 19, 2023 · What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ... Reata Pharmaceuticals Inc. (NASDAQ:RETA) shares, rose in value on Wednesday, 05/24/23, with the stock price up by 20.37% to the previous day’s close as strong demand from buyers drove the stock to $95.36. Actively observing the price movement in the last trading, the stock closed the session at $79.22, falling within a …Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ... vgt price Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. In a report released on May 23, Annabel Samimy from Stifel Nicolaus …May 23, 2023 · See the latest Reata Pharmaceuticals Inc Class A stock price (NASDAQ:RETA), related news, valuation, dividends and more to help you make your investing decisions. May 25, 2023 · Reata Pharmaceuticals Inc. (NASDAQ:RETA) shares, rose in value on Wednesday, 05/24/23, with the stock price up by 20.37% to the previous day’s close as strong demand from buyers drove the stock to $95.36. Actively observing the price movement in the last trading, the stock closed the session at $79.22, falling within a range of $85.30 and $96 ... Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC … bmea stock Reata’s stock soared nearly 200% Wednesday to $93.17. It closed Tuesday at $30.99 before the Skyclarys announcement. Related: Plano-based Reata’s stock soars 28% after scoring $350 million ...May 25, 2023 · Swiss National Bank grew its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA - Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 64,800 shares of the company's stock after ac Reata’s stock jumps 175% in premarket trading after FDA approval Mar. 1, … pakwan restaurant fremont menu Free-Float. 81,4%. More Financials. Company. Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapies. The Company concentrates on small-molecule therapeutics with mechanisms of action for the treatment of severe, life-threatening diseases.May 19, 2023 · What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ... nicky jam restaurant fresh mint deliverySwiss National Bank grew its position in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA - Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.The fund owned 64,800 shares of the company's stock after acquiring an additional 1,500 shares during …About Reata Pharmaceuticals, Inc. 5320 LEGACY DRIVE, PLANO, Texas, 75024, United States +1 972 865-2219 https://www.reatapharma.com. Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical ...May 23, 2023 · Institutional investors own 76.13% of the company's stock. Insider Buying and Selling at Reata Pharmaceuticals. In other Reata Pharmaceuticals news, insider Michael D. Wortley sold 894 shares of Reata Pharmaceuticals stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $84.81, for a total transaction of ... sakis pizza About Reata Pharmaceuticals, Inc. 5320 LEGACY DRIVE, PLANO, Texas, 75024, United States +1 972 865-2219 https://www.reatapharma.com. Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical ... rinaldi's italian deliDiscover historical prices for RETA stock on Yahoo Finance. View daily, weekly or monthly format back to when Reata Pharmaceuticals, Inc. stock was issued. Reata expects the drug to be available commercially in the second quarter of 2023. Several analysts hiked their price targets on the stock after the FDA’s approval for Skyclarys. In addition to ...Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...Reata's stock jumps 175% in premarket trading after FDA approval. Shares of Reata Pharmaceuticals Inc. RETA soared about 175% in premarket trading on Wednesday, the day after the Food and Drug Administration approved Skyclarys, a treatment for Friedreich's ataxia, a... 2 months ago - Market Watch.Reata's stock jumps 175% in premarket trading after FDA approval Shares of Reata Pharmaceuticals Inc. RETA soared about 175% in premarket trading on Wednesday, the day after the Food and Drug Administration approved Skyclarys, a treatment for Friedreich's ataxia, a... cork and batter menu See the latest Reata Pharmaceuticals Inc Class A stock price (NASDAQ:RETA), related news, valuation, dividends and more to help you make your investing decisions.What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ...Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news …What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ...Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ... e finance RETA Latest After Hours Trades. Select time range to see more trades: Last 100 Trades. After Hours Time (ET) After Hours Price. After Hours Share Volume. 19:38:55. $95.9. 1.Reata Pharmaceuticals, Inc. (RETA Quick Quote RETA - Free Report) reported a first-quarter 2023 adjusted loss of $3.14 per share, wider than the Zacks Consensus Estimate and our model estimate of ...For 2023, Wall Street called for a loss of $8.80 per share and $42.5 million in sales. Shares have a best-possible IBD Digital Relative Strength Rating of 99. This means Reata shares trade in the ...Reata's stock jumps 175% in premarket trading after FDA approval. Shares of Reata Pharmaceuticals Inc. RETA soared about 175% in premarket trading on Wednesday, the day after the Food and Drug Administration approved Skyclarys, a treatment for Friedreich's ataxia, a... 2 months ago - Market Watch.Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) After-Hours Stock Quotes - …Goldman Sachs analyst Paul Choi maintained a Buy rating on Reata … jacky's galaxie north providence A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.May 19, 2023 · What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ... Reata Pharmaceuticals Inc. RETA reported second-quarter 2021 loss of $2.00 per share, narrower than the Zacks Consensus Estimate of a loss of $2.13. However, the above loss included stock-based ...14 hours ago · In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ... gque bbq Reata Pharmaceuticals ’ RETA shares have more than doubled in 2023. The main reason for the surge is the approval of its Skyclarys or omaveloxolone, across a broad patient population of an ultra ...Mar 1, 2023 · Reata Pharmaceuticals stock surged on Wednesday after it received U.S. regulatory approval for a drug treating a rare neurological disorder. Analysts expect the decision to generate strong revenue ... Reata Pharmaceuticals, Inc. (RETA Quick Quote RETA - Free Report) reported a first-quarter 2023 adjusted loss of $3.14 per share, wider than the Zacks Consensus Estimate and our model estimate of ...May 19, 2023 · What was the 52-week low for Reata Pharmaceuticals stock? The low in the last 52 weeks of Reata Pharmaceuticals stock was 18.47. According to the current price, Reata Pharmaceuticals is 433.03% ... desert spots near me Reata Pharmaceuticals ( NASDAQ: RETA) lost ~18% in the morning hours Wednesday despite reporting better than expected revenue for Q1 2023 as the biotech announced its plans to discontinue its ...Find real-time RETA - Reata Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Stock analysis for Reata Pharmaceuticals Inc (RETA:NASDAQ GM) including stock …Reata expects the drug to be available commercially in the second quarter of 2023. Several analysts hiked their price targets on the stock after the FDA’s approval for Skyclarys. In addition to ... upwork stockView the latest Reata Pharmaceuticals Inc. Cl A (RETA) stock price, news, historical charts, analyst ratings and financial information from WSJ.22 hours ago · Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ... May 10, 2023 · Reata Pharmaceuticals ( NASDAQ: RETA) lost ~18% in the morning hours Wednesday despite reporting better than expected revenue for Q1 2023 as the biotech announced its plans to discontinue its ... yemen gate restaurant nazareth dinerReata Pharmaceuticals RETA stock skyrocketed almost 200% on Wednesday, a day after the FDA approved its drug Skyclarys, or omaveloxolone, across a broad patient population of an ultra-rare disease ...View the latest Reata Pharmaceuticals Inc. Cl A (RETA) stock price, news, historical charts, analyst ratings and financial information from WSJ. 22 hours ago · Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ... A high-level overview of Reata Pharmaceuticals, Inc. (RETA) stock. Stay up to date on … asada cantina kitchen 22 hours ago · Shares of Reata Pharmaceuticals ( NASDAQ: RETA) and PTC Therapeutics ( NASDAQ: PTCT) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate ... Goldman Sachs analyst Paul Choi maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report) today. The company’s shares closed yesterday at $79.22. According to TipRanks, Choi is ...May 11, 2023 · Reata Pharmaceuticals, Inc. (RETA Quick Quote RETA - Free Report) reported a first-quarter 2023 adjusted loss of $3.14 per share, wider than the Zacks Consensus Estimate and our model estimate of ... See the latest Reata Pharmaceuticals Inc Class A stock price (NASDAQ:RETA), related news, valuation, dividends and more to help you make your investing decisions.See the latest Reata Pharmaceuticals Inc Class A stock price (NASDAQ:RETA), related news, valuation, dividends and more to help you make your investing decisions.14 hours ago · In a report released on May 23, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Reata Pharmaceuticals (RETA – Research Report), with a price target of $110.00. The company’s ... Reata sheds 18% after halting kidney disease programs msn.com - May 10 at 1:21 PM: Reata Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call Presentation seekingalpha.com - May 10 at 1:17 PM: SG Americas Securities LLC Lowers Stock Holdings in Reata Pharmaceuticals, Inc. (NASDAQ:RETA) marketbeat.com - May 10 at …What was the 52-week low for Reata Pharmaceuticals stock? The low in …